Entering text into the input field will update the search result below

Merck in pact with Finish pharma Orion Corporation for cancer agents

Jul. 13, 2022 6:30 AM ETMerck & Co., Inc. (MRK)SGENBy: Dulan Lokuwithana, SA News Editor

Merck & Co. headquarters in Silicon Valley

Sundry Photography/iStock Editorial via Getty Images

  • Merck (NYSE:MRK) and Finnish pharmaceutical company Orion Corporation announced an agreement on Wednesday to develop and commercialize cancer agents targeted at cytochrome P450 11A1, an enzyme important for steroid production.
  • The global development

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About MRK

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Merck & Co., Inc.
Roche Holding AG
AstraZeneca PLC
Pfizer Inc.
Johnson & Johnson
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.